The role of surgical resection following imatinib treatment in patients with recurrent or metastatic gastrointestinal stromal tumors: results of propensity score analyses.
about
Treatment and Prognoses in Patients With Primary Gastrointestinal Stromal Tumors ≥10 cm: A Single-Institution Experience in China.Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.Role of surgery in patients with focally progressive gastrointestinal stromal tumors resistant to imatinib.Neoadjuvant imatinib: longer the better, need to modify risk stratification for adjuvant imatinib.Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal Tumor.Partial response to imatinib treatment in a patient with unresectable gastrointestinal stromal tumor: A case report and mini literature reviewRole of metastasectomy for recurrent/metastatic gastrointestinal stromal tumors based on an analysis of the Kinki GIST registry.Imatinib dose escalation versus sunitinib as a second-line treatment against advanced gastrointestinal stromal tumors: A nationwide population-based cohort study.Ultrasound-Guided Intraoperative Radiofrequency Ablation and Surgical Resection for Liver Metastasis from Malignant Gastrointestinal Stromal Tumors.Identification of preoperative factors associated with outcomes following surgical management of intra-abdominal recurrent or metastatic GIST following neoadjuvant tyrosine kinase inhibitor therapy.Cytoreductive Surgery for Metastatic Gastrointestinal Stromal Tumors Treated With Tyrosine Kinase Inhibitors: A 2-institutional Analysis.[Intra-abdominal and retroperitoneal sarcomas].
P2860
Q36196622-DB8D40E8-52B1-4FC9-BE8B-E4D3CBF72C91Q36225803-74CBBE9E-9D28-4E05-9C82-FC867E8399C7Q36656850-F311CEBF-8092-4B81-A5EB-549A808D6234Q37131713-791B5CA8-DB1B-428E-9000-FEF3D7AB7A8BQ37367438-F34FB07C-4FC6-4991-9A52-0E498FE954C8Q38971422-3D80D3F1-0F1B-46ED-B882-96DE96DFA7ABQ39755099-A6ECE771-8623-4289-BCEE-09F1578CBFC8Q42378511-B00AFEBA-A426-4305-9C69-DE57E3BA0A7FQ49237178-A9ABD77F-EFFF-428D-9400-1FEF54028335Q49966909-EAD11772-F42C-479A-B1E8-1D2FB01A1A3DQ50696576-2BB119A4-3162-42EA-BE69-4D62F3DE0470Q53163059-B0646033-0DDC-43AE-8279-F0076517258A
P2860
The role of surgical resection following imatinib treatment in patients with recurrent or metastatic gastrointestinal stromal tumors: results of propensity score analyses.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
The role of surgical resection ...... of propensity score analyses.
@en
The role of surgical resection ...... of propensity score analyses.
@nl
type
label
The role of surgical resection ...... of propensity score analyses.
@en
The role of surgical resection ...... of propensity score analyses.
@nl
prefLabel
The role of surgical resection ...... of propensity score analyses.
@en
The role of surgical resection ...... of propensity score analyses.
@nl
P2093
P2860
P1476
The role of surgical resection ...... of propensity score analyses.
@en
P2093
Baek-Yeol Ryoo
Byeong Seok Sohn
Byung Sik Kim
Chan Wook Kim
Chang Sik Yu
Hwa Jung Kim
Jeong Hwan Yook
Ki-Hun Kim
Min-Hee Ryu
Seong Joon Park
P2860
P2888
P304
P356
10.1245/S10434-014-3866-4
P577
2014-07-01T00:00:00Z
P6179
1015443318